关于牛皮病的管道治疗方法
André L Ribeiro1, Leandro L Leite2, Raphael Micheroli3
1Department of Rheumatology, Hospital de Clínicas, Porto Alegre, Brazil; Hospital Moinhos de Vento, Porto Alegre, Brazil.
Best practice & research. Clinical rheumatology
|September 23, 2025
概括
新的牛皮病治疗方法正在开发中,包括新的向疗法和组合策略. 研究正在探索微生物组和代谢干预措施,以改善患者的治疗结果,并解决牛皮病管理中的未满足需求.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 牛皮病带来复杂的挑战,持续缓解率有限.
- 目前针对TNF,IL-17,IL-23,PDE4和JAK-STAT通路的治疗方法往往不足.
- 迫切需要新的治疗策略来有效管理牛皮病.
研究的目的:
- 审查针对牛皮病的新兴管道治疗方法.
- 探索新的免疫调节剂和组合疗法.
- 讨论辅助策略,如微生物组和代谢干预.
主要方法:
- 关于牛皮病管道治疗的当前文献的综述.
- 分析新的治疗点,包括JAK-STAT,IL-17和IL-23通路.
- 探索组合疗法,微生物组和代谢干预措施.
主要成果:
- 管道中的治疗包括新的JAK-STAT抑制剂 (TYK2,JAK1),下一代IL-17抑制剂和IL-23向疗法.
- 组合疗法 (双生物/小分子) 在耐火病例中表现有前途.
- 针对微生物组的治疗方法和代谢干预措施 (益生菌,GLP-1激动剂) 正在研究中.
结论:
- 创新的治疗方法为牛皮病提供了个性化医疗的机会.
- 挑战包括长期安全性,治疗顺序和最佳组合策略.
- 进一步的研究,包括RCT和现实世界的数据,对于定义有效的牛皮病管理至关重要.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
465
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
465
Inflammatory Bowel Disease IV: Pharmacological Management
528
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
528
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
Drugs for Treatment of Ulcerative Colitis in IBD
463
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
463
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
441
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
441

